Any radioactive source used in brachytherapy must be fully characterized according the TG-43 protocol in order to be approved by the FDA for clinical use. One of the parameters that must be characterized per the protocol is the anisotropy function. Iridium-192 is the most common and standard source to use in brachytherapy. The anisotropy of a specific iridium-192 brachytherapy seed has been analyzed using Gafchromic film dosimetry as part of the characterization needed for FDA approval.

• This report represents the work of one or more WPI undergraduate students submitted to the faculty as evidence of completion of a degree requirement. WPI routinely publishes these reports on its website without editorial or peer review.

Creator

• Beinstein, Nicole Elizabeth
• Fong, Kenneth Brian

Publisher

• Worcester Polytechnic Institute

Identifier

• E-project-042618-090435

Advisor

• Medich, David Christopher

Year

• 2018

Date created

• 2018-04-26

Resource type

• Major Qualifying Project

Major

• Physics

Rights statement

• In Copyright